Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by fasttrack5 on May 14, 2021 10:50am

Theralase

Way past due for some positive news/event.
.21 is not cutting it :)
just sayin.
Comment by Oilminerdeluxe on May 14, 2021 11:12am
What is next on the TLT agenda? Could it be updates from the covid stuff? Otherwise we might perhaps have to wait until the next quarterly update or something. I think I still had hair when I first heard of TLT, he he.
Comment by Rumpl3StiltSkin on May 14, 2021 3:03pm
I think the AGM might be next? I think we will see some more data from some front this summer. I hope.
Comment by 99942Apophis on May 14, 2021 3:35pm
Oilminerdeluxe wrote What is next on the TLT agenda? Could it be updates from the covid stuff? Otherwise we might perhaps have to wait until the next quarterly update or something. I think I still had hair when I first heard of TLT, he he. Chances are good Oilminerdeluxe that progress on their possible Covid-19 Super Coronavirus Vaccine will be the next NR with an update on number of new treated ...more  
Comment by Pandora on May 14, 2021 3:41pm
The 5 year 37.5 cent warrants expire in November 2021. Never thought we would see that happen.
Comment by DJDawg on May 14, 2021 4:13pm
Is that a good thing or bad thing.....?
Comment by tamarindo1 on May 14, 2021 5:08pm
The .50c warrants were extended from 9Jan/21 to 9 Jan/23. Why not extend these ones? I wonder how many are owned by top tier management.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250